KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 48 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,022,000 | +11.6% | 1,746,591 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $2,707,000 | -32.0% | 1,746,591 | 0.0% | 0.01% | -30.0% |
Q2 2014 | $3,982,000 | -15.9% | 1,746,591 | 0.0% | 0.01% | -23.1% |
Q1 2014 | $4,733,000 | +22.4% | 1,746,591 | +99.6% | 0.01% | +18.2% |
Q4 2013 | $3,868,000 | -2.2% | 875,000 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $3,955,000 | – | 875,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 910,699 | $2,076,000 | 0.92% |
Opaleye Management Inc. | 320,000 | $730,000 | 0.63% |
BVF INC/IL | 1,162,000 | $2,649,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,786,783 | $6,354,000 | 0.26% |
SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $821,000 | 0.20% |
WALL STREET ASSOCIATES | 608,300 | $1,387,000 | 0.12% |
Old West Investment Management, LLC | 58,838 | $134,000 | 0.08% |
SSI INVESTMENT MANAGEMENT LLC | 173,360 | $394,000 | 0.04% |
PRIMECAP MANAGEMENT CO/CA/ | 4,475,700 | $10,205,000 | 0.01% |
First Eagle Investment Management, LLC | 1,746,591 | $3,982,000 | 0.01% |